Systemic <i>miRNA-195</i> Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
Helen Heneghan(University College Dublin), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway)
Cited by 312
Related Papers
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer
|Breast Cancer Research|2009|447
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS
|Journal of Medical Genetics|2016|217
Prognostic significance of oestrogen receptor β in breast cancer
|British journal of surgery|2000|71